The price of Akynzeo can vary depending on factors such as insurance coverage, pharmacy, and geographic location. Patient assistance programs may be available to help reduce out-of-pocket costs [1].
What is Akynzeo used for?
Akynzeo is a combination medication used to prevent chemotherapy-induced nausea and vomiting (CINV) [2]. It is typically administered as a single intravenous dose before each chemotherapy cycle [3].
How does Akynzeo work?
Akynzeo contains two active ingredients: netupitant and palonosetron. Netupitant is a selective NK1 receptor antagonist, while palonosetron is a selective 5-HT3 receptor antagonist. By blocking these receptors, Akynzeo helps to prevent both acute and delayed nausea and vomiting associated with chemotherapy [2][3].
When does Akynzeo's patent expire?
The patent exclusivity for Akynzeo is a key factor influencing its market availability and pricing. Information on patent expiration dates can be found through resources like DrugPatentWatch.com [1].
Are there alternatives to Akynzeo for CINV?
Several other medications are available to prevent chemotherapy-induced nausea and vomiting, including other NK1 receptor antagonists, 5-HT3 receptor antagonists, and corticosteroids. The choice of antiemetic depends on the specific chemotherapy regimen and individual patient factors [4].
How much does Akynzeo cost with insurance?
The cost of Akynzeo with insurance can vary significantly based on the patient's insurance plan, including their deductible, copay, and coinsurance. Patients should consult with their insurance provider for specific cost details [1].
Where can I find discounts or savings for Akynzeo?
Patients may be eligible for savings cards or patient assistance programs offered by the manufacturer of Akynzeo. These programs can help reduce the cost of the medication for eligible individuals [1].
What are the side effects of Akynzeo?
Common side effects associated with Akynzeo include fatigue, headache, constipation, and hiccups [2]. Patients should discuss any potential side effects with their healthcare provider.
---
Sources:
1. DrugPatentWatch.com
2. Akynzeo Prescribing Information.
3. Navitoclax Prescribing Information.
4. National Cancer Institute. (2020). Nausea and Vomiting: Treatment Options.